Showing results (71-80 of 116) with videos related to

Sort By:
Pageof 12
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 21, 2017
A phase II study of a human anti-PDGFRα monoclonal antibody (olaratumab, IMC-3G3) in previously treated patients with metastatic gastrointestinal stromal tumorsA J Wagner, H Kindler, H Gelderblom, et al.
The British Journal of Surgery|February 21, 2017
Timing of completion lymphadenectomy after positive sentinel node biopsy in patients with melanomaC M C Oude Ophuis, A C J van Akkooi, P Rutkowski, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 13, 2022
Analysis of efficacy and safety of vismodegib therapy in patients with advanced basal cell carcinoma - real world multicenter cohort studyM Słowińska, M Dudzisz-Śledź, P Sobczuk, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 5, 2014
Long-term follow-up of patients with GIST undergoing metastasectomy in the era of imatinib -- analysis of prognostic factors (EORTC-STBSG collaborative study)S Bauer, P Rutkowski, P Hohenberger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2022
Biomarkers of treatment benefit with atezolizumab plus vemurafenib plus cobimetinib in BRAFV600 mutation-positive melanomaC Robert, K D Lewis, R Gutzmer, et al.
Molecular Psychiatry|April 13, 2019
Behavioral changes and growth deficits in a CRISPR engineered mouse model of the schizophrenia-associated 3q29 deletionTimothy P Rutkowski, Ryan H Purcell, Rebecca M Pollak, et al.
Gynecologic Oncology|May 22, 2016
Impact of chemotherapy in uterine sarcoma (UtS): review of 13 clinical trials from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) involving advanced/metastatic UtS compared to other soft tissue sarcoma (STS) patients treated with first line chemotherapyI Ray-Coquard, E Rizzo, J Y Blay, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 9, 2020
Prognostic impact of baseline tumour immune infiltrate on disease-free survival in patients with completely resected, BRAFv600 mutation-positive melanoma receiving adjuvant vemurafenibP A Ascierto, K D Lewis, A M Di Giacomo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 14, 2020
Cobimetinib plus atezolizumab in BRAFV600 wild-type melanoma: primary results from the randomized phase III IMspire170 studyH Gogas, B Dréno, J Larkin, et al.
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|March 1, 2023
Spinal tumours: recommendations of the Polish Society of Spine Surgery, the Polish Society of Oncology, the Polish Society of Neurosurgeons, the Polish Society of Oncologic Surgery, the Polish Society of Oncologic Radiotherapy, and the Polish Society of Orthopaedics and TraumatologyA Maciejczak, R Gasik, D Kotrych, et al.
Pageof 12